Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  Agfa-Gevaert    AGFB   BE0003755692

AGFA-GEVAERT (AGFB)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

AGFA-GEVAERT : Annual General Meeting of Agfa-Gevaert

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/24/2012 | 02:31pm CET
  • Press Release
  • Mortsel (Belgium)
  • April 24, 2012 02:00

At Agfa-Gevaert's Annual General Meeting today, all the voting points on the agenda were approved. These included the approval of the 2011 financial statements, the allocation of the result as well as the discharge of directors and auditors.

The shareholders also approved the reappointment of De Wilde J Management BVBA, with permanent representative Julien De Wilde, and Christian Leysen as members of the Board of Directors. Finally, the General Meeting resolved, in accordance with article 556 of the Companies Code, to approve the change-of-control provisions, as stipulated in the Facility Agreement dated May 31, 2011 with Fortis Bank SA/NV, ING Belgium SA/NV and KBC Bank NV on the one hand and Agfa HealthCare NV, Agfa Graphics NV and Agfa-Gevaert NV on the other hand.

At the consequent Extraordinary General Meeting today - all the voting points on the agenda, all of them regarding changes in the articles of association - were approved, except for voting point n°3 regarding the spread in time of the variable remuneration.


Viviane Dictus
Director Corporate Communication
Septestraat 27
2640 Mortsel - Belgium
tel+32 (0) 3 444 7124
fax+32 (0) 3 444 4485
[email protected]
Johan Jacobs
Corporate Press Relations Manager
Septestraat 27
2640 Mortsel - Belgium
tel+32 (0) 3 444 8015
fax+32 (0) 3 444 4485
[email protected]
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AGFA-GEVAERT
11/27 AGFA GEVAERT : showcases innovations in card security and manufacturing at TRUST..
11/20 AGFA GEVAERT : RADLogics to Showcase at RSNA 2017 its Virtual-Resident™--M..
11/19 AGFA GEVAERT : Graphics has acquired software developer and reseller Bodoni Syst..
11/08 AGFA GEVAERT : publishes its third quarter 2017 results – regulated inform..
11/08 AGFA-GEVAERT PUBLISHES ITS THIRD QUA : 45 a.m. CET
11/03AGFA-GEVAERT NV : quaterly earnings release
10/13 AGFA GEVAERT : reports on study aiming at focused growth
10/11 AGFA GEVAERT : rapporteert over studie met het oog op doelgerichte groei
10/11 AGFA GEVAERT : reports on study aiming at focused growth
09/25 EMC : Agfa HealthCare and Federation des Hopitaux Luxembourgeois sign contract f..
More news
News from SeekingAlpha
11/08 Agfa-Gavaert NV reports Q3 results
08/23 Agfa-Gavaert's (AFGVF) CEO Christian Reinaudo on Q2 2017 Results - Earnings C..
08/23 Agfa-Gavaert NV reports Q2 results
08/23 Agfa-Gavaert NV 2017 Q2 - Results - Earnings Call Slides
05/09 Agfa-Gavaert NV reports Q1 results
Financials (€)
Sales 2017 2 473 M
EBIT 2017 159 M
Net income 2017 70,0 M
Finance 2017 138 M
Yield 2017 -
P/E ratio 2017 7,62
P/E ratio 2018 6,59
EV / Sales 2017 0,21x
EV / Sales 2018 0,17x
Capitalization 668 M
Chart AGFA-GEVAERT
Duration : Period :
Agfa-Gevaert Technical Analysis Chart | AGFB | BE0003755692 | 4-Traders
Technical analysis trends AGFA-GEVAERT
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 5,00 €
Spread / Average Target 29%
EPS Revisions
Managers
NameTitle
Christian Reinaudo President, Chief Executive Officer & Director
Julien de Wilde Chairman
Kris Hoornaert Chief Financial Officer
Jozef Cornu Non-Executive Director
Willy W. Duron Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
AGFA-GEVAERT5.80%787
THERMO FISHER SCIENTIFIC INC.33.21%76 376
DANAHER19.71%65 491
INTUITIVE SURGICAL81.55%41 579
ROYAL PHILIPS12.67%36 583
BOSTON SCIENTIFIC CORPORATION18.86%35 305